HBF Reports and Publications
The Hepatitis B Foundation and Blumberg Institute have produced the following reports and manuscripts toward the elimination of hepatitis B and related scientific advances. Below on this page are several valuable research reports.
The Foundation's annual reports are posted here.
Journal articles recommended by our Emerging Scholars Scientific and Medical Advisory Board, which is a new service, are posted here.
A selection of recent, peer-reviewed journal articles and other scholarly publications that were written by
Hepatitis B Foundation public health researchers and collaborators are posted here.
Health Insurance Costs Impacting Shoppers Living with Hepatitis B (2020) This report is a resource to help people living with hepatitis B make informed decisions when choosing a health insurance plan. It can also be shared with policymakers to inform them of potentially discriminatory benefit plan designs in various states.
Externally Led Patient-Focused Drug Development was the subject of a virtual (online) meeting held on June 9, 2020, to hear directly from patients about their perspectives on living with chronic hepatitis B and their experiences with treatments to improve the development of new drugs in the research pipeline. The patient perspective is critical in helping the U.S. Food and Drug Administration (FDA) understand the context in which regulatory decisions are made for new drugs. This input was gathered to inform FDA’s decisions and oversight both during drug development and during its review of new treatments. The meeting format was very interactive with more than 650 attendees and 300-plus comments submitted. Download the full report here.
Opportunities for Federal-Community Collaboration to Reduce Disparities in Hepatitis B: 2014-2016, Hep B United (2020) The purpose of this document is to identify areas where Hep B United and other community-based coalitions can work with federal agencies and within their local coalition to further the priority areas identified in the U.S. Department of Health and Human Services.
Roadmap for a Cure, Hepatitis B Foundation (2017)
This report provides an overview of our research agenda, with information on priority research areas and potential funding.
Research Priorities for the Discovery of a Cure for Chronic Hepatitis B: Report of a Workshop, Science Direct (2017)
This publication summarizes the opinions of 30 experts in the fields of hepatitis B and liver cancer research convened by the Hepatitis B Foundation to identify projects they deemed important to the goal of finding a cure for chronic hepatitis B and D and the diseases with which these viral infections are associated.
Hepatitis B Foundation and FDA Meeting Report, Hepatitis B Foundation (2017)
Representatives from the Hepatitis B Foundation and HBV Forum met with representatives from the US FDA in March 2017 to discuss clinical development of hepatitis B therapeutics.